The future CRO/CDMO will offer end-to-end solutions and operate as a large pharma or biotech company Read more
India and Colombia exchange views on cooperation in biotechnology sector and vaccine tie-up Read more
‘Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets’ Read more